Early recognition of alpha-1 antitrypsin deficiency and considerations for liver transplantation.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Gastroenterology & hepatology

• Publication date

  2013-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 23983656PMCID PMC3754769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosis and management of patients with α1-antitrypsin (A1AT) deficiency.

  2012cited by this paper
• Long‐term outcome in 42 pediatric liver transplant patients with alpha 1‐antitrypsin deficiency: a single‐center experience

  2011cited by this paper
• Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells

  2011cited by this paper
• Gene therapy for alpha-1 antitrypsin deficiency.

  2011cited by this paper
• Alpha-1-antitrypsin deficiency: outcomes after liver transplantation.

  2008cited by this paper
• Liver transplantation for alpha-1-antitrypsin deficiency in children

  2000cited by this paper
• Transplantation for end stage liver disease related to alpha 1 antitrypsin.

  1996cited by this paper

• USF2 and TFEB compete in regulating lysosomal and autophagy genes

  2024cites this paper
• Autophagy of the ER: the secretome finds the lysosome

  2023cites this paper
• The N-Degron Pathway Mediates ER-phagy.

  2019cites this paper
• Severe postoperative wound healing disturbance in a patient with alpha‐1‐antitrypsin deficiency: the impact of augmentation therapy

  2015cites this paper
• Alpha-1 Antitrypsin Deficiency — A Missed Opportunity in COPD?

  2014cites this paper